A new hypothesis for how sex steroid hormones regulate bone mass

Journal of Clinical Investigation

Volumn 111, Issue 11, 2003, Pages 1641-1643

  Lorenzo, Joseph ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE; LIGAND; STEROID;

BONE MASS; GENITAL SYSTEM; HORMONAL REGULATION; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BONE; FEMALE; HUMAN; MALE; METABOLISM; NOTE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BONE AND BONES; ESTROGENS; FEMALE; HUMANS; LIGANDS; MALE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEROIDS;

EID: 0038481192     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318812     Document Type: Review

References (16)

1. Cato, A.C., Nestl, A., and Mink, S. 2002. Rapid actions of steroid receptors in cellular signaling pathways. Sci. STKE. 138:RE9.
2. Shupnik, M.A. 2002. Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis. J Neuroendocrinol. 14:85-94.
3. Riggs, B.L., and Hartmann, L.C. 2003. Selective estrogen-receptor modulators: mechanisms of action and application to clinical practice. N. Engl. J Med. 348:618-629.
4. Paech, K., et al. 1997. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1508-1510.
5. Saville, B., et al. 2000. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp 1) promoter elements. J. Biol. Chem. 275:5379-5387.
6. Szego, C.M., and Davis, J.S. 1967. Adenosine 3′,5′ -monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U. S. A. 58:1711-1718.
7. Pietras, R.J., and Szego, C.M. 1977. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 265:69-72.
8. Filardo, E.J., Quinn, J.A., Bland, K.I., and Frackelton, A.R-,Jr. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14:1649-1660.
9. Kousteni, S., et al. 2001. Nongenotropic, sex-non-specific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104:719-730.
10. Jilka, R.L., et al. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:88-91.
11. Kousteni, S., et al. 2002. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 298:843-846.
12. Kousteni, S., et al. 2003. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J. Clin. Invest. 111:1651-1664. doi:10.1172/JCI200317261.
13. Manabe, N., et al. 2001. Connection between B lymphocyte and osteoclast differentiation pathways. J. Immunol. 167:2625-2631.
14. Sato, T., Shibata, T., Ikeda, K., and Watanabe, K. 2001. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J. Bone Miner. Res. 16:2215-2221.
15. Katavic, V., et al. 2003. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone. In press.
16. Miller, G. 2002. Divorcing estrogen's bright and dark sides. Science. 298:723-724.